Skip to main content
NVSNovartis AGSell4.9·$159.90
NVS · Decision

Should you buy Novartis (NVS)?

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Verdict
SELL
Score
4.9/10
Price
$159.90
Entry / Take Profit (TP) / Stop Loss (SL)
/ $157.36 / $153.82

Engine methodology range

Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.

What the engine is tracking

  • Strong Margins And RoeStable
  • Leverage Penalty Debt RiskStable
  • Technical Breakout Above 200 MaStable
  • +1 more pillar — see the Why tab for full reasoning

→ Full pillar scorecard with all 4 pillars + per-dimension breakdown

When this thesis breaks

Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Strong Margins And Roe

    Trip ifNet margin falls below 18% for 2 consecutive quarters.

  • P2Leverage Penalty Debt Risk

    Trip ifDebt-to-equity ratio rises above 1.5 in any reported quarter.

  • P3Technical Breakout Above 200 Ma

    Trip ifPrice falls below the 200-day moving average and remains below for more than 20 trading days.

  • P4Earnings Miss And Yield Trap

    Trip ifEPS surprise falls below negative 5% in at least 3 of the next 4 quarters, or a dividend cut of more than 20% is announced.

How the engine reached this verdict

1. Direct answer

TrendMatrix's engine output for Novartis AG (NVS) is SELL_IF_HOLDING with medium conviction, score 4.9/10 at $159.90. The F-path SELL output reflects an overall score of 4.4 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. Asymmetry R:R of -1.88 is supplementary context, not the trigger.

2. What would change the verdict

The dominant failed gate is reward-to-risk (NEGATIVE). SELL flips back toward HOLD if reward-to-risk recovers above its threshold AND a co-failing gate also clears. The strongest-cleared gate today is MOMENTUM:6.4>=5.5.

3. What the engine sees

On the bull side: High-quality business. On the bear side: Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.2): -0.5; Negative news sentiment (-0.67). Active engine warnings: V8: Target reached (-15.9% upside), V9 Gate Failed: ASYMMETRY:-1.9=NEGATIVE.

4. Entry, target, and stop

The engine's exit framework anchors to a tactical sell band near $159.90, with structural invalidation at $153.82. The asymmetric R:R against a reversal hypothesis is -1.88 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).

For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates NVS — 10-dimension breakdown →

Bull case

  • High-quality business

Bear case

  • Analyst target reached - limited upside remaining
  • Leverage penalty (D/E 1.2): -0.5
  • Negative news sentiment (-0.67)
Home Stocks NVS Buy or sell?